NOX 5.75% 8.2¢ noxopharm limited

Ann: Noxopharm Secures Key European Patent Allowance for Veyonda, page-28

  1. 588 Posts.
    lightbulb Created with Sketch. 357
    The US documents are background and supporting information, nothing too interesting.

    The EU documents are just Noxopharm requesting modifications to the patent description suggested by the EU. Nothing controversial that will impact either the claims or the grant, imo.
 
watchlist Created with Sketch. Add NOX (ASX) to my watchlist
(20min delay)
Last
8.2¢
Change
-0.005(5.75%)
Mkt cap ! $23.96M
Open High Low Value Volume
8.7¢ 8.7¢ 8.1¢ $50.65K 608.4K

Buyers (Bids)

No. Vol. Price($)
3 131400 8.2¢
 

Sellers (Offers)

Price($) Vol. No.
8.6¢ 7168 1
View Market Depth
Last trade - 16.10pm 16/08/2024 (20 minute delay) ?
NOX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.